Literature DB >> 30251880

Uncontrolled severe asthma: starting from the unmet needs.

Marco Caminati1, Gianenrico Senna1.   

Abstract

Mesh：

Year:  2018        PMID： 30251880     DOI： 10.1080/03007995.2018.1528218

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


× No keyword cloud information.
  5 in total

Review 1.  Targeting TSLP in Asthma.

Authors:  Jane R Parnes; Nestor A Molfino; Gene Colice; Ubaldo Martin; Jonathan Corren; Andrew Menzies-Gow
Journal:  J Asthma Allergy       Date:  2022-06-03

Review 2.  Uncontrolled Asthma: Unmet Needs in the Management of Patients.

Authors:  Marco Caminati; Rachele Vaia; Fabiana Furci; Gabriella Guarnieri; Gianenrico Senna
Journal:  J Asthma Allergy       Date:  2021-05-03

3.  New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic.

Authors:  Marco Caminati; Diego Bagnasco; Rachele Vaia; Gianenrico Senna
Journal:  Biologics       Date:  2019-05-22

4.  Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience.

Authors:  A Vianello; M Caminati; M Andretta; A M Menti; S Tognella; G Senna; L Degli Esposti
Journal:  World Allergy Organ J       Date:  2019-05-10       Impact factor: 4.084

5.  Use of Biologic Therapies in the Treatment of Asthma - A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation.

Authors:  Fraence Hardtstock; Julia Krieger; Thomas Wilke; Marco Lukas; Bernhard Ultsch; Robert Welte; Renate Quinzler; Ulf Maywald; Hartmut Timmermann
Journal:  J Asthma Allergy       Date:  2022-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.